{"id":"W2150274550","doi":"10.1034/j.1600-0447.2001.00299.x","title":"CYP2D6 and CYP2C19 genotype‐based dose recommendations for antidepressants:
a first step towards subpopulation‐specific dosages","year":2001,"lang":"en","type":"article","venue":"Acta Psychiatrica Scandinavica","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":423,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"CYP2D6; CYP2C19; Pharmacogenetics; Pharmacology; Dose; Medicine; Tricyclic; Drug; Pharmacokinetics; Therapeutic drug monitoring; Genotype; Cytochrome P450; Internal medicine; Biology; Genetics; Gene; Metabolism","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1359243710060618,"score_gpt":0.4378611409673693,"score_spread":0.3019367699613075,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}